HAI (health action international) ACCISS

Resolving Problems and Limitations of Sources and Supply of Insulin" 2015-2020 multicenter study . PHASE II (2018-2021) The second phase focuses on piloting the tools and interventions developed in Phase I at country level, while continuing to work globally to address inequities and inefficiencies in the insulin market. Our Phase II work streams are: Work with global partners to develop evidence-based tools that address worldwide barriers to insulin access, and strengthen tools already developed Develop, with national partners in four countries, comprehensive and contextualised national strategies to address the range of challenges that people requiring insulin face, and to pilot and evaluate the interventions Further expand the ACCISS network and develop civil society networks, amplified in international/regional/national fora, to reduce, or eliminate, the barriers to insulin access The study is co-led by Dr Margaret Ewen and Molly Lepeska (HAI) and Dr David Beran (Geneva University Hospitals and the University of Geneva). It also brings together a large group of leading international experts as members of its Advisory Group. The study is funded by a grant from The Leona M. and Harry B. Helmsley Charitable Trust and Stichting ICF. 1.CAPZ 2.KRSU 3.Employees of OshSU 1 . Momunova A.A. Rysbekova G.S. 4.Organizations of practical health care In the second phase (2018-2020), the ACCISS project, together with partners in Peru, Tanzania, Mali and Kyrgyzstan, piloted tools and interventions ( http://accisstoolkit.haiweb.org/ ) at the country level, while continuing to tackle inequities and inefficiencies. in the insulin market globally.